var gpdrcookie = (document.cookie.match(/^(?:.*;)?\s*cookie_notice_accepted\s*=\s*([^;]+)(?:.*)?$/)||[,null])[1];
if(gpdrcookie == 'true') {
//console.log('init full GTM tracking');
(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-KL6986C');
} else {
//run anonymous GA script
//console.log('init anonymous GA tracking');
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})
(window,document,'script','https://www.googletagmanager.com/gtag/js?id=UA-6441755-21','ga');
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
//gtag('consent', 'default', { 'ad_storage': 'denied', 'analytics_storage': 'denied'});
gtag('config', 'UA-6441755-21', { 'anonymize_ip': true });
window.dataLayer.push({'event' : 'ga_custom_dimensions','anonymous_user' : '1'});
}
Sol Global cannabis firm has increased its stake in HeavenlyRx
var gpdrcookie = (document.cookie.match(/^(?:.*;)?\s*cookie_notice_accepted\s*=\s*([^;]+)(?:.*)?$/)||[,null])[1];
if(gpdrcookie == 'true') {
window.addEventListener('load', function() {
console.log('init OneSignal');
OneSignal.init(window._oneSignalInitOptions);
OneSignal.showSlidedownPrompt();
});
}
Sol Global, a Toronto-based international cannabis investment firm, has increased its stake in a privately held CBD company.
The firm announced Friday it spent 15 million Canadian dollars ($11.5 million) in HeavenlyRx. The purchase brings Sol Global to a 42% stake in HeavenlyRx.
The announcement comes less than a week after Sol Global raised CA$50 million ($37.5 million) and announced plans to increase investment in CBD companies.
Earlier this week, HeavenlyRx bought 15 million shares in Jones Soda Co. for $9 million with an eye toward developing CBD-infused beverages with the brand. HeavenlyRx now holds 39% of the Seattle-based beverage manufacturer.
Sol Global trades on the Canadian Securities Exchange under the ticker symbol SOL.